title: Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection.
abstract: Clostridium difficile is the leading cause of healthcare-associated infections in the United States. Clinically, C. difficile-associated disease can present as asymptomatic colonization, self-limited diarrheal illness or severe colitis (that may result in death). This variability in disease course and outcomes suggests that host factors play an important role as key determinants of disease severity. Currently, there are several scoring indices to estimate severity of C. difficile-associated disease. Leukocytosis and renal failure are considered to be the most important predictors of C. difficile disease severity in hosts with a normal immune system. The degree of leukocytosis which is considered significant for severe disease and how it is scored vary amongst scoring indices. None of the scores have been prospectively validated, and while total WBC count is useful to estimate the magnitude of the host response in most patient populations, in immune-compromised patients like those receiving chemotherapy, solid organ transplant patients or hematopoietic stem cell transplants the WBC response can be variable or even absent making this marker of severity difficult to interpret. Other cellular subsets like neutrophils, eosinophils and lymphocytes provide important information about the host immune status and play an important role in the immune response against C. difficile infection. However, under the current scoring systems the role of these cellular subsets have been underestimated and only total white blood cell counts are taken into account. In this review we highlight the role of host leukocyte response to C. difficile challenge in the normal and immunocompromised host, and propose possible ways that would allow for a better representation of the different immune cell subsets (neutrophils, lymphocytes and eosinophils) in the current scoring indices.
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB 6109, ML 0560, Cincinnati, OH 45267, USA. Electronic address: vargasen@ucmail.uc.edu.
authors.forename: Edwin
authors.initials: E
authors.lastname: Vargas
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB 6109, ML 0560, Cincinnati, OH 45267, USA.
authors.forename: Senu
authors.initials: S
authors.lastname: Apewokin
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB 6109, ML 0560, Cincinnati, OH 45267, USA.
authors.forename: Rajat
authors.initials: R
authors.lastname: Madan
mesh_terms: D003015:Clostridium Infections / Q000150:complications / Q000276:immunology* / Q000473:pathology*; D006801:Humans; D016867:Immunocompromised Host; D007962:Leukocytes / Q000276:immunology*; D007964:Leukocytosis / Q000473:pathology*; D011446:Prospective Studies
keywords: Clostridium difficile; Disease severity; Leukocytosis